Study Objectives: Rapid eye movement (REM) sleep behavior disorder (RBD) and other sleep disturbances are frequent in leucine-rich, glioma inactivated protein 1-IgG (LGI1) and contactin-associated protein 2-IgG (CASPR2) autoimmunity, yet polysomnographic analyses of these disorders remain limited. We aimed to characterize clinical presentations and analyze polysomnographic manifestations, especially quantitative REM sleep without atonia (RSWA) in LGI1/CASPR2-IgG seropositive (LGI/CASPR2+) patients.
Methods: We retrospectively analyzed clinical and polysomnographic features and quantitative RSWA between LGI1+/CASPR2+ patients and age-sex matched controls. Groups were compared with Wilcoxon rank-sum and chi-square tests. Combined submentalis and anterior tibialis (SM + AT) RSWA was the primary outcome.
Results: Among 11 (LGI1+, n = 9; CASPR2+, n = 2) patients, Morvan syndrome sleep features were present in seven (63.6%) LGI1+/CASPR2+ patients, with simultaneous insomnia and dream enactment behavior (DEB) in three (27.3%), and the most common presenting sleep disturbances were DEB (n = 5), insomnia (n = 5), and sleep apnea (n = 8; median apnea-hypopnea index = 15/hour). Median Epworth Sleepiness Scale was nine (range 3-24; n = 10), with hypersomnia in four (36.4%). LGI1+/CASPR2+ patients had increased N1 sleep (p = .02), decreased REM sleep (p = .001), and higher levels of SM + AT any RSWA (p < .001). Eight of nine (89%) LGI1+ exceeded RBD RSWA thresholds (DEB, n = 5; isolated RSWA, n = 3). RSWA was greater in AT than SM. All 10 LGI1+/CASPR2+ patients treated with immunotherapy benefitted, and 5/10 had improved sleep disturbances.
Conclusions: LGI1/CASPR2-IgG autoimmunity is associated with prominent dream enactment, insomnia, RSWA, sleep apnea, and shallower sleep. Polysomnography provides objective disease markers in LGI1+/CASPR2+ autoimmunity and immunotherapy may benefit associated sleep disturbances.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842336 | PMC |
| http://dx.doi.org/10.1093/sleep/zsab297 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnostic utility of magnetic resonance imaging in autoimmune encephalitis: prognostic implications.
Acta Radiol
January 2025
R Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
Background: The role of imaging in autoimmune encephalitis (AIE) remains unclear, and there are limited data on the utility of magnetic resonance imaging (MRI) to diagnose, treat, or prognosticate AIE.
Purpose: To evaluate whether MRI is a diagnostic and prognostic marker for AIE and assess its efficacy in distinguishing between various AIE subtypes.
Material And Methods: We analyzed data from 96 AIE patients from our prospective autoimmune registry.
Recent advances in autoimmune encephalitis.
Arq Neuropsiquiatr
December 2024
Hospital Israelita Albert Einstein, Instituto do Cérebro, São Paulo SP, Brazil.
Since the description of autoimmune encephalitis (AE) associated with N-methyl-D-aspartate receptor antibodies (anti-NMDARE) in 2007, more than 12 other clinical syndromes and antibodies have been reported. In this article, we review recent advances in pathophysiology, genetics, diagnosis pitfalls, and clinical phenotypes of AE associated with cell surface antibodies and anti-GAD associated neurological syndromes. Genetic studies reported human leukocyte antigen (HLA) associations for anti-LGI1, anti-Caspr2, anti-IgLON5, and anti-GAD.
View Article and Find Full Text PDFAutoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing Performance.
Neurol Neuroimmunol Neuroinflamm
November 2024
From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands.
Background And Objectives: Autoimmune encephalitis (AIE) and paraneoplastic neurologic syndromes (PNSs) encompass a heterogeneous group of antibody-associated disorders. Both the number of syndromes and commercially available antibody tests have increased considerably over the past decade. High-quality population-based data on epidemiology of these disorders and real-world performance of antibody tests are needed.
View Article and Find Full Text PDFIsaacs' syndrome: Clinical and paraclinical perspectives in a series of cases.
Curr J Neurol
January 2024
Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Isaacs' syndrome is a rare condition that causes persistent muscle activity, leading to symptoms like twitching, stiffness, and cramps, and is associated with peripheral nerve hyperexcitability.
- A study involving 12 patients examined their clinical signs, diagnostic tests, antibody presence (like LGI1 and CASPR2), and the search for related cancers, which ultimately returned inconclusive results.
- The patients responded well to treatments like carbamazepine or gabapentin, along with immunotherapies, resulting in full recovery within 3-6 months.
MRI findings in autoimmune encephalitis.
Rev Neurol (Paris)
November 2024
Charité - Universitätsmedizin Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany; Humboldt-Universität zu Berlin, Berlin School of Mind and Brain, Berlin, Germany; Charité - Universitätsmedizin Berlin, Einstein Center for Neurosciences Berlin, Berlin, Germany. Electronic address:
Article Synopsis
- In NMDA receptor encephalitis, most patients have normal MRIs during acute episodes, but subtle lesions can occur; these lesions may signal overlaps with conditions like multiple sclerosis or neuromyelitis optica.
- Other types, such as limbic encephalitis related to LGI1, CASPR2, and GAD antibodies, show specific hyperintensities in the medial temporal lobe on MRI, while GABA receptor encephalitides present different patterns of lesions, underscoring the importance of MRI in diagnosing autoimmune encephalitis and differentiating it from other disorders.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!